Stimulant Use Disorder (StUD) is a chronic but treatable medical condition involving the problematic use of stimulants such as methamphetamine, cocaine, or other stimulant substances. Stimulant use can significantly impact physical health, mental well-being, relationships, employment, and overall quality of life. In Canada, stimulant use, particularly methamphetamine use, has increased in recent years and is associated with substantial health and social harms. ^[1]

Stimulant Replacement Therapy (SRT), also known as prescribed psychostimulant treatment, is an emerging evidence-based approach that may help reduce cravings, withdrawal symptoms, and reliance on the unregulated stimulant supply. While no medications are currently approved in Canada specifically for stimulant use disorder, prescribed psychostimulants are increasingly being used in specialized addiction medicine settings as part of a comprehensive treatment plan. ^[1]

Our Stimulant Replacement Therapy Program provides evidence-based, person-centered care for individuals experiencing stimulant use disorder. We recognize that recovery is different for everyone and work collaboratively with clients to develop individualized treatment plans that support their goals.

Treatment is provided in a respectful, non-judgmental, and trauma-informed environment focused on improving health, safety, and quality of life. ^[1]

Medication-assisted treatment for stimulant use disorder can:

• Reduce stimulant cravings and withdrawal symptoms ^[2,3]
• Support reductions in methamphetamine, cocaine, and other stimulant use ^[2,4]
• Reduce reliance on the unregulated stimulant supply ^[2,3]
• Improve engagement and retention in treatment programs ^[2,4]
• Enhance participation in counselling, recovery planning, and other psychosocial supports ^[2,4]
• Reduce harms associated with illicit stimulant use, including infectious disease transmission, overdose risk, and mental health complications ^[2,3]
• Improve overall physical health, mental well-being, and day-to-day functioning ^[2,4]
• Support greater stability in housing, employment, education, and personal relationships ^[2,3]
• Be used alongside counselling, behavioural therapies, contingency management, and harm reduction services to improve treatment outcomes ^[4,5]
• Help individuals work toward their personal goals, whether that involves reducing stimulant use, achieving abstinence, or improving quality of life ^[2,3]

Medication options are discussed with each client to determine the safest and most effective treatment approach based on their goals, medical history, and individual needs.

Our SRT Program may be appropriate for individuals who:

• Have difficulty reducing or stopping stimulant use
• Experience cravings for methamphetamine, cocaine, or other stimulants
• Experience withdrawal symptoms when attempting to stop stimulant use
• Are seeking safer alternatives to the unregulated stimulant supply
• Have experienced stimulant-related harms and would like additional support
• Are interested in exploring medication-assisted treatment options

Our team is committed to providing compassionate, evidence-based care that reduces stigma and supports individuals wherever they are in their recovery journey. Whether your goal is reducing stimulant use, improving stability, or pursuing long-term recovery, we are here to help.

Whether you are ready to begin treatment or simply exploring your options, call or walk in today. Our dedicated team will take the time to discuss our programs & services, answer your questions, and help you find the support that best meets your needs.

Individuals
You can refer yourself in person or by phone
Call us at:
Moncton: (506) 854-4673
Saint John: (506) 214-4673

Physicians
Referrals can be sent via fax or email
Moncton Fax: (506) 204-6146 | Saint John Fax: (506) 214-4674
Email: [email protected]

Business Hours

Moncton:
Monday – Friday8:30 am – 2:00 pm
Saturday – Sunday9:00 am – 12:00 pm
Holidays9:00 am – 12:00 pm

Saint John:
Monday – Friday8:30 am – 2:00 pm
Saturday – Sunday9:00 am – 12:00 pm
Holidays9:00 am – 12:00 pm

1. Palis H, MacDonald S. Incorporating Prescription Psychostimulants into the Continuum of Care for People with Stimulant Use Disorder in Canada. Canadian Medical Association Journal (CMAJ), 2023. https://www.cmaj.ca/content/195/27/E934
2. National Institute on Drug Abuse (NIDA). Medications for Opioid Use Disorder. https://nida.nih.gov/research-topics/medications-opioid-use-disorder
3. National Institute on Drug Abuse (NIDA). Opioid Use Disorder Treatment. https://nida.nih.gov/nidamed-medical-health-professionals/treatment/opioid-use-disorder-treatment
4. Addiction Policy Forum. Medications to Treat Opioid Addiction Reduce Overdose Fatalities and Improve Patient Outcomes (2025). https://www.addictionpolicy.org/post/medications-to-treat-opioid-addiction-reduce-overdose-fatalities-and-improve-patient-outcomes
5. Substance Abuse and Mental Health Services Administration (SAMHSA). Medications to Treat Opioid Addiction Research Report (2024). https://www.samhsa.gov/resource/ebp/medications-treat-opioid-addiction-research-report